Showing 5,541 - 5,560 results of 93,057 for search '(( a ((we decrease) OR (teer decrease)) ) OR ( i ((largest decrease) OR (larger decrease)) ))', query time: 1.42s Refine Results
  1. 5541

    Recombination of Autodissociated Water Ions in a Nanoscale Pure Water Droplet by Soonho Kwon (1402972)

    Published 2025
    “…We found that the self-diffusion of water dramatically decreases in droplets with a diameter below 2.2 nm. …”
  2. 5542

    Recombination of Autodissociated Water Ions in a Nanoscale Pure Water Droplet by Soonho Kwon (1402972)

    Published 2025
    “…We found that the self-diffusion of water dramatically decreases in droplets with a diameter below 2.2 nm. …”
  3. 5543

    Recombination of Autodissociated Water Ions in a Nanoscale Pure Water Droplet by Soonho Kwon (1402972)

    Published 2025
    “…We found that the self-diffusion of water dramatically decreases in droplets with a diameter below 2.2 nm. …”
  4. 5544

    Recombination of Autodissociated Water Ions in a Nanoscale Pure Water Droplet by Soonho Kwon (1402972)

    Published 2025
    “…We found that the self-diffusion of water dramatically decreases in droplets with a diameter below 2.2 nm. …”
  5. 5545

    Recombination of Autodissociated Water Ions in a Nanoscale Pure Water Droplet by Soonho Kwon (1402972)

    Published 2025
    “…We found that the self-diffusion of water dramatically decreases in droplets with a diameter below 2.2 nm. …”
  6. 5546

    Recombination of Autodissociated Water Ions in a Nanoscale Pure Water Droplet by Soonho Kwon (1402972)

    Published 2025
    “…We found that the self-diffusion of water dramatically decreases in droplets with a diameter below 2.2 nm. …”
  7. 5547

    Dimethyl Sulfoxide Perturbs Cell Cycle Progression and Spindle Organization in Porcine Meiotic Oocytes by Xuan Li (137217)

    Published 2016
    “…Interestingly, we did not observe the formation of the large first polar body and symmetric division for porcine oocytes treated with DMSO, contrary to findings reported in mice. 3% DMSO treatment could inhibit cumulus expansion, increase nuclear abnormality, disturb spindle organization, decrease reactive oxygen species level, and elevate mitochondrial membrane potential of porcine oocytes. …”
  8. 5548

    Table 1_Assessing virtual reality presence through physiological measures: a comprehensive review.xlsx by Danping Wang (1888792)

    Published 2025
    “…The physiological measurements focused mainly on head movements, as well as electromyographic and electrocardiographic activity. Over time, a gradual decrease in the use of questionnaires is noted, with a growing preference for physiological markers to define presence in VR. …”
  9. 5549

    Spinocerebellar ataxia type 11-associated alleles of <i>Ttbk2</i> dominantly interfere with ciliogenesis and cilium stability by Emily Bowie (543704)

    Published 2018
    “…SCA11 is caused by mutations in the gene encoding the Serine/Threonine kinase Tau tubulin kinase 2 (TTBK2) that result in premature truncations of the protein. We previously showed that TTBK2 is a key regulator of the assembly of primary cilia <i>in vivo</i>. …”
  10. 5550

    Table_1_A Functional Indel Polymorphism Within MIR155HG Is Associated With Sudden Cardiac Death Risk in a Chinese Population.DOCX by Qing Zhang (1802)

    Published 2021
    “…Collectively, we have successfully identified a SCD risk conferring polymorphism in the MIR155HG gene and a likely biological mechanism for the decreased risk of SCD associated with the deletion allele. …”
  11. 5551

    Analysis of VEGF-A Regulated Gene Expression in Endothelial Cells to Identify Genes Linked to Angiogenesis by Corban G. Rivera (19353)

    Published 2011
    “…After treatment with VEGF-A, we found increasing expression of HIF-1α, APP, HIV-1 tat interactive protein 2, and MEF2C, while endoglin, liprin β1 and HIF-2α had decreasing expression across three endothelial cell lines. …”
  12. 5552

    image5_Chemoresistance in Breast Cancer Patients Associated With Changes in P2X7 and A2A Purinergic Receptors in CD8+ T Lymphocytes.jpeg by Victor Manuel Ruiz-Rodríguez (9704699)

    Published 2020
    “…In this sense, as the chemotherapeutic treatment stimulates immune system response, we evaluated the expression and function of P2X7 and A2A receptors in CD8<sup>+</sup> T cells before and four months after BRCA patients received neoadjuvant chemotherapy. …”
  13. 5553

    image5_Chemoresistance in Breast Cancer Patients Associated With Changes in P2X7 and A2A Purinergic Receptors in CD8+ T Lymphocytes.jpeg by Victor Manuel Ruiz-Rodríguez (9704699)

    Published 2020
    “…In this sense, as the chemotherapeutic treatment stimulates immune system response, we evaluated the expression and function of P2X7 and A2A receptors in CD8<sup>+</sup> T cells before and four months after BRCA patients received neoadjuvant chemotherapy. …”
  14. 5554

    image4_Chemoresistance in Breast Cancer Patients Associated With Changes in P2X7 and A2A Purinergic Receptors in CD8+ T Lymphocytes.jpeg by Victor Manuel Ruiz-Rodríguez (9704699)

    Published 2020
    “…In this sense, as the chemotherapeutic treatment stimulates immune system response, we evaluated the expression and function of P2X7 and A2A receptors in CD8<sup>+</sup> T cells before and four months after BRCA patients received neoadjuvant chemotherapy. …”
  15. 5555

    image1_Chemoresistance in Breast Cancer Patients Associated With Changes in P2X7 and A2A Purinergic Receptors in CD8+ T Lymphocytes.jpeg by Victor Manuel Ruiz-Rodríguez (9704699)

    Published 2020
    “…In this sense, as the chemotherapeutic treatment stimulates immune system response, we evaluated the expression and function of P2X7 and A2A receptors in CD8<sup>+</sup> T cells before and four months after BRCA patients received neoadjuvant chemotherapy. …”
  16. 5556

    image3_Chemoresistance in Breast Cancer Patients Associated With Changes in P2X7 and A2A Purinergic Receptors in CD8+ T Lymphocytes.jpeg by Victor Manuel Ruiz-Rodríguez (9704699)

    Published 2020
    “…In this sense, as the chemotherapeutic treatment stimulates immune system response, we evaluated the expression and function of P2X7 and A2A receptors in CD8<sup>+</sup> T cells before and four months after BRCA patients received neoadjuvant chemotherapy. …”
  17. 5557

    image4_Chemoresistance in Breast Cancer Patients Associated With Changes in P2X7 and A2A Purinergic Receptors in CD8+ T Lymphocytes.jpeg by Victor Manuel Ruiz-Rodríguez (9704699)

    Published 2020
    “…In this sense, as the chemotherapeutic treatment stimulates immune system response, we evaluated the expression and function of P2X7 and A2A receptors in CD8<sup>+</sup> T cells before and four months after BRCA patients received neoadjuvant chemotherapy. …”
  18. 5558

    image2_Chemoresistance in Breast Cancer Patients Associated With Changes in P2X7 and A2A Purinergic Receptors in CD8+ T Lymphocytes.jpeg by Victor Manuel Ruiz-Rodríguez (9704699)

    Published 2020
    “…In this sense, as the chemotherapeutic treatment stimulates immune system response, we evaluated the expression and function of P2X7 and A2A receptors in CD8<sup>+</sup> T cells before and four months after BRCA patients received neoadjuvant chemotherapy. …”
  19. 5559

    datasheet1_Chemoresistance in Breast Cancer Patients Associated With Changes in P2X7 and A2A Purinergic Receptors in CD8+ T Lymphocytes.docx by Victor Manuel Ruiz-Rodríguez (9704699)

    Published 2020
    “…In this sense, as the chemotherapeutic treatment stimulates immune system response, we evaluated the expression and function of P2X7 and A2A receptors in CD8<sup>+</sup> T cells before and four months after BRCA patients received neoadjuvant chemotherapy. …”
  20. 5560

    image2_Chemoresistance in Breast Cancer Patients Associated With Changes in P2X7 and A2A Purinergic Receptors in CD8+ T Lymphocytes.jpeg by Victor Manuel Ruiz-Rodríguez (9704699)

    Published 2020
    “…In this sense, as the chemotherapeutic treatment stimulates immune system response, we evaluated the expression and function of P2X7 and A2A receptors in CD8<sup>+</sup> T cells before and four months after BRCA patients received neoadjuvant chemotherapy. …”